WebCompany Description: Galapagos has formed its own archipelago of drugs to treat bone and joint ailments and other diseases. The company uses its proprietary genomic drug … WebMar 31, 2024 · The Investor Relations website contains information about Galapagos NV's business for stockholders, potential investors, and financial analysts. SEC Filings …
Galapagos NV (GLPG) Q4 2024 Earnings Call Transcript
WebApr 5, 2024 · FAQs for Galapagos NV ADR Stock Sponsor Center Transparency is our policy. Learn how it impacts everything we do Transparency is how we protect the integrity of our work and keep empowering... WebNov 5, 2024 · Galapagos Market Cap $3B Today's Change (0.41%) $0.18 Current Price $44.02 Price as of January 6, 2024, 4:00 p.m. ET GLPG earnings call for the period … coko sunshine topic
Galapagos increases share capital through subscription right …
WebGalapagos NV forms part of the Bel20 index (top 20 listed companies) on Euronext Brussels, the AMX Index (Amsterdam Midcap-index) on Euronext Amsterdam, and the NBI (Nasdaq Biotechnology Index) on Nasdaq in New York. ... Investor relations activities. In 2024 we attracted additional coverage from sell-side analysts. Currently, 17 analysts … WebApr 6, 2024 · Galapagos NV finds support from accumulated volume at $37.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. WebCompany Description: Galapagos has formed its own archipelago of drugs to treat bone and joint ailments and other diseases. The company uses its proprietary genomic drug-discovery technology to develop medicines to treat … dr louis botha ophthalmologist